Cite
Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.
MLA
Chan, Sze Ling, et al. “Genetic Diversity of Variants Involved in Drug Response and Metabolism in Sri Lankan Populations: Implications for Clinical Implementation of Pharmacogenomics.” Pharmacogenetics and Genomics, vol. 26, no. 1, Jan. 2016, pp. 28–39. EBSCOhost, https://doi.org/10.1097/FPC.0000000000000182.
APA
Chan, S. L., Samaranayake, N., Ross, C. J. D., Toh, M. T., Carleton, B., Hayden, M. R., Teo, Y. Y., Dissanayake, V. H. W., & Brunham, L. R. (2016). Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics. Pharmacogenetics and Genomics, 26(1), 28–39. https://doi.org/10.1097/FPC.0000000000000182
Chicago
Chan, Sze Ling, Nilakshi Samaranayake, Colin J D Ross, Meng Tiak Toh, Bruce Carleton, Michael R Hayden, Yik Ying Teo, Vajira H W Dissanayake, and Liam R Brunham. 2016. “Genetic Diversity of Variants Involved in Drug Response and Metabolism in Sri Lankan Populations: Implications for Clinical Implementation of Pharmacogenomics.” Pharmacogenetics and Genomics 26 (1): 28–39. doi:10.1097/FPC.0000000000000182.